NASDAQ

Viking Therapeutics, Inc. (VKTX)

♥ 393 Thanks from members

Live price chart, market sentiment, and community perspectives for Viking Therapeutics, Inc. (NASDAQ: VKTX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Viking Therapeutics ManagementLeadership: Brian Lian (CEO)Leadership: Greg Sullivan (CFO)Holder: Baker Bros. AdvisorsHolder: BlackRock Inc.Holder: Vanguard GroupVK2735 (GLP-1/GIP receptor agonist)VK2809 (THR-beta agonist)#VKTX stock#Viking Therapeutics#biotech clinical trials#NASDAQ pharma#obesity drug stock